Rosetta Martiniello‐Wilks

<i>In Vivo</i> Gene Therapy for Prostate Cancer: Preclinical Evaluation of Two Different Enzyme-Directed Prodrug Therapy Systems Delivered by Identical Adenovirus Vectors

Rosetta Martiniello‐Wilks, Juanita García-Aragón, Mirella M. Daja et al. · Human Gene Therapy · 1998 · 92 citations

Evaluation of Cell Cycle Arrest in Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls of the MTS Assay

Eileen McGowan, Nikki Alling, Elise Jackson et al. · PLoS ONE · 2011 · 72 citations · Full text

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

Dale J. Voeks, Rosetta Martiniello‐Wilks, Victoria J. Madden et al. · Gene Therapy · 2002 · 61 citations

Urology, Gene Vector, Prostatic Disease +3

Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice

Aparajita Khatri, Bing Zhang, Eboney Doherty et al. · The Journal of Gene Medicine · 2006 · 39 citations

Gene‐directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease

Rosetta Martiniello‐Wilks, Allison Dane, Dale J. Voeks et al. · The Journal of Gene Medicine · 2004 · 39 citations